Neuroplast
PrivateLast Round
Series B
Nov 17, 2021
Total Funding Raised
$15.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuroplast is a biotechnology company that develops the autologous stem cell platform product Neuro-Cells®, a treatment to combat neurodegeneration resulting from trauma, disease and ageing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuroplast Comparables
Compare Neuroplast with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Matricelf Ltd | 77% | |
| Brainstorm Cell Therapeutics Inc. | 77% | |
| ReNetX Bio | 74% | |
Neuroplast Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 17, 2021 | ||||
| Series A | Feb 19, 2020 |
Neuroplast Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 819 Capital Partners | Series A |
| Brightlands Venture Partners | Series B, Series A |
| Lumana Invest | Series B |
| LIOF | Series B, Series A |
| Netherlands Enterprise Agency | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
Grew 43% QoQ from 7 to 10 employees.
Neuroplast Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuroplast's valuation, stock price, and market status.